Department of Undersea and Hyperbaric Medicine, Gulhane Training and Research Hospital, University of Health Science, Ankara, Turkey.
Department of Internal Medicine, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Int Marit Health. 2021;72(3):228-236. doi: 10.5603/IMH.2021.0042.
A hyperbaric oxygen (HBO) treatment session carries a high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission since patients stay in a closed area for 2 hours. The primary aim of this study was to evaluate the effects of the preventive measures taken in the HBO centre.
This study evaluated the measures taken during the coronavirus disease 2019 (COVID-19) pandemic for multiplace hyperbaric chamber operated in department (Health Sciences University-Gulhane Research and Training Hospital, Ankara, Turkey) between March 16th, 2020 and December 31st, 2020. The medical records of patients who underwent HBO treatment during this period were evaluated retrospectively. Their demographic attributes, the presence of risk factors, HBO indications, HBO session data, and COVID-19 inquiry forms were analysed.
A total of 122 patients underwent HBO treatment, and 150 people were subjected to pressure tolerance test (PTT). No COVID-19 case was treated with HBO in our department. The hyperbaric chamber was operated 608 times in total. Of these, 9.7% (n = 59) procedures were carried out under emergency conditions, and 10% (n = 61) were PTTs. Accordingly, 59.8% (n = 73) of the HBO-treated patients were considered at risk for a severe clinical presentation of SARS-CoV-2. SARS-CoV-2 was detected in 5.7% (n = 7) of the HBO-treated patients during the HBO treatment period. Besides, two inside attendants (14.3%) were diagnosed with COVID-19. There were only two concurrent cases in the same session among SARS-CoV-2 positive cases. The records revealed that these patients were sitting three seats away from each other. Another patient was sitting in between the two infected patients but was not diagnosed with SARS-CoV-2.
There is no clear evidence that these two patients infected each other; on the contrary, since no other patient was infected with SARS-CoV-2 in the same session, we may suspect that the infections were coincidental. The measures taken in our department seem to suffice in preventing in-session transmission of COVID-19 and similar infectious diseases in an HBO centre.
高压氧 (HBO) 治疗过程中,由于患者需要在封闭环境中停留 2 小时,因此存在严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 传播的高风险。本研究的主要目的是评估 HBO 中心采取的预防措施的效果。
本研究评估了 2020 年 3 月 16 日至 2020 年 12 月 31 日期间在土耳其安卡拉健康科学大学古尔哈内研究与培训医院运行的多床位高压舱期间采取的针对 2019 年冠状病毒病 (COVID-19) 大流行的措施。回顾性分析了在此期间接受 HBO 治疗的患者的病历。分析了他们的人口统计学特征、危险因素、HBO 适应证、HBO 治疗过程数据和 COVID-19 问询表。
共有 122 名患者接受了 HBO 治疗,150 人接受了压力耐受测试 (PTT)。在我们科室没有 COVID-19 患者接受 HBO 治疗。高压舱总共运行了 608 次。其中,9.7%(n=59)的程序是在紧急情况下进行的,10%(n=61)是 PTT。因此,59.8%(n=73)的 HBO 治疗患者被认为有严重 SARS-CoV-2 临床症状的风险。在 HBO 治疗期间,在 5.7%(n=7)的 HBO 治疗患者中检测到了 SARS-CoV-2。此外,两名内部工作人员(14.3%)被诊断出 COVID-19。在 SARS-CoV-2 阳性病例中,只有两例同时出现在同一治疗过程中。记录显示,这些患者彼此相隔三个座位。另一名患者坐在两名感染者之间,但未被诊断出 SARS-CoV-2。
没有明确证据表明这两例患者相互感染;相反,由于在同一治疗过程中没有其他患者感染 SARS-CoV-2,我们可能怀疑感染是偶然的。我们科室采取的措施似乎足以防止 COVID-19 和类似传染病在 HBO 中心的治疗过程中传播。